CG Oncology, Inc. CGON

Set alert

Price alert · CGON

All alert types
64.68 USD +1.21 +1.91%

At close · Oct 30

64.68 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
64.46 × 2
Ask
64.76 × 2
60.63 Day range 65.55
37.37 52-week range 80.68
YTD
+55.78%
1 year
+52.30%
Open
63.02
Prev close
63.47
Mkt cap
5.73B
Vol
870.33K
Avg vol
868.03K
EPS
-2.69
P/E
0.00
Div yield
0.00%
More statistics
Low
60.63
High
65.55
Forward P/E
-21.41
Beta
0.28
Short ratio
8.13
Inst. own
113.45%
Dividend
0.00
Ex-div date
Earnings
Nov 13, 2026
50-d avg
69.69
200-d avg
65.86
1y target
91.08

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for CGON has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

60.61 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -20.0×
FY 2021: -133×FY 2022: -56.3×FY 2023: -36.4×FY 2024: -20.3×FY 2025: -20.0×
FY 2021 5y median -36.4× FY 2025
P/S 794×
FY 2021: 239×FY 2022: 12968×FY 2023: 12142×FY 2024: 1574×FY 2025: 794×
FY 2021 5y median 1574× FY 2025
P/B 4.3×
FY 2021: 61.5×FY 2022: 19.8×FY 2023: 13.4×FY 2024: 2.4×FY 2025: 4.3×
FY 2021 5y median 13.4× FY 2025
P/FCF -24.2×
FY 2021: -180×FY 2022: -83.1×FY 2023: -54.2×FY 2024: -22.7×FY 2025: -24.2×
FY 2021 5y median -54.2× FY 2025
EV/EBITDA -20.0×
FY 2021: -197×FY 2022: -67.9×FY 2023: -50.8×FY 2024: -17.4×FY 2025: -20.0×
FY 2021 5y median -50.8× FY 2025
EV/Sales 788×
FY 2021: 235×FY 2022: 12590×FY 2023: 12106×FY 2024: 1348×FY 2025: 788×
FY 2021 5y median 1348× FY 2025
FCF Yield -4.1%
FY 2021: -0.6%FY 2022: -1.2%FY 2023: -1.8%FY 2024: -4.4%FY 2025: -4.1%
FY 2021 5y median -1.8% FY 2025

Profitability

Gross Margin -15.0%
FY 2021: 99.9%FY 2022: 92.1%FY 2023: -22327.5%FY 2024: -7108.3%FY 2025: -15.0%
FY 2021 5y median -15.0% FY 2025
Operating Margin -4722.1%
FY 2021: -121.7%FY 2022: -18453.4%FY 2023: -27180.9%FY 2024: -10067.3%FY 2025: -4722.1%
FY 2021 5y median -10067.3% FY 2025
Net Margin -3985.0%
FY 2021: -124.0%FY 2022: -18556.5%FY 2023: -23827.0%FY 2024: -7729.5%FY 2025: -3985.0%
FY 2021 5y median -7729.5% FY 2025
ROE -21.4%
FY 2021: -31.9%FY 2022: -28.3%FY 2023: -26.3%FY 2024: -12.0%FY 2025: -21.4%
FY 2021 5y median -26.3% FY 2025
ROIC -25.0%
FY 2021: -22.6%FY 2022: -24.9%FY 2023: -29.8%FY 2024: -15.6%FY 2025: -25.0%
FY 2021 5y median -24.9% FY 2025
ROA -20.3%
FY 2021: -21.9%FY 2022: -24.0%FY 2023: -24.4%FY 2024: -11.7%FY 2025: -20.3%
FY 2021 5y median -21.9% FY 2025

Growth (YoY)

Revenue 254.7%
FY 2021: 0.0%FY 2022: -98.2%FY 2023: 6.8%FY 2024: 458.3%FY 2025: 254.7%
FY 2021 FY 2025
Operating Income -66.4%
FY 2021: 0.0%FY 2022: -179.6%FY 2023: -57.3%FY 2024: -106.8%FY 2025: -66.4%
FY 2021 FY 2025
EPS (diluted) -47.5%
FY 2021: 0.0%FY 2022: -135.7%FY 2023: -54.5%FY 2024: -38.2%FY 2025: -47.5%
FY 2021 FY 2025
Free Cash Flow -67.8%
FY 2021: 0.0%FY 2022: -116.8%FY 2023: -53.2%FY 2024: -72.8%FY 2025: -67.8%
FY 2021 FY 2025

Financial Health

Current Ratio 24.6×
FY 2021: 9.8×FY 2022: 9.5×FY 2023: 13.6×FY 2024: 35.3×FY 2025: 24.6×
FY 2021 5y median 13.6× FY 2025
Quick Ratio 24.6×
FY 2021: 9.8×FY 2022: 9.5×FY 2023: 13.6×FY 2024: 35.3×FY 2025: 24.6×
FY 2021 5y median 13.6× FY 2025
Debt / Equity 0.0×
FY 2021: 0.4×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2021: 3.1×FY 2022: 2.0×FY 2023: 0.1×FY 2024: 2.9×FY 2025: 0.2×
FY 2021 5y median 2.0× FY 2025
Interest Coverage 0.0×
FY 2021: -28.0×FY 2022: -35246×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31